STERIS Corporation Announces Date of Fiscal 2009 Fourth Quarter and Full Year Earnings Release and Conference Call
22 4월 2009 - 7:51PM
PR Newswire (US)
MENTOR, Ohio, April 21 /PRNewswire-FirstCall/ -- STERIS Corporation
(NYSE: STE) today announced that it will issue its fiscal 2009
fourth quarter and full year earnings before the market opens on
May 7, 2009, followed by a conference call at 10:00 a.m. Eastern
time. The conference call can be heard live over the Internet at
http://www.steris-ir.com/ or via phone by dialing 1-800-369-8428 in
the United States and Canada, and 1-773-799-3378 internationally,
then referencing the password "STERIS". For those unable to listen
to the conference call live, a replay will be available from 12:00
p.m. Eastern time on May 7, 2009, until 5:00 p.m. Eastern time on
May 21, 2009, either over the Internet at http://www.steris-ir.com/
or via phone by calling 1-866-419-8655 in the United States and
Canada, and 1-203-369-0784 internationally. About STERIS The
mission of STERIS Corporation is to provide a healthier today and
safer tomorrow through knowledgeable people and innovative
infection prevention, decontamination and health science
technologies, products and services. The Company's more than 5,000
dedicated employees around the world work together to supply a
broad array of solutions by offering a combination of equipment,
consumables and services to healthcare, pharmaceutical, industrial
and government customers. The Company is listed on the New York
Stock Exchange under the symbol STE. For more information, visit
http://www.steris.com/. This news release and the conference call
referenced here may contain statements concerning certain trends,
expectations, forecasts, estimates, or other forward-looking
information affecting or relating to the Company or its industry
that are intended to qualify for the protections afforded
"forward-looking statements" under the Private Securities
Litigation Reform Act of 1995 and other laws and regulations.
Forward-looking statements speak only as to the date of this
report, and may be identified by the use of forward-looking terms
such as "may," "will," "expects," "believes," "anticipates,"
"plans," "estimates," "projects," "targets," "forecasts,"
"confidence," and "seeks," or the negative of such terms or other
variations on such terms or comparable terminology. Many important
factors could cause actual results to differ materially from those
in the forward-looking statements including, without limitation,
disruption of production or supplies, changes in market conditions,
political events, pending or future claims or litigation,
competitive factors, technology advances, and changes in government
regulations or the application or interpretation thereof. Other
risk factors are described in the Company's Form 10-K and other
securities filings. Many of these important factors are outside
STERIS's control. No assurances can be provided as to any future
financial results. Unless legally required, the Company does not
undertake to update or revise any forward-looking statements even
if events make clear that any projected results, express or
implied, will not be realized. Other potential risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements include, without
limitation, (a) the potential for increased pressure on pricing
that leads to erosion of profit margins, (b) the possibility that
market demand will not develop for new technologies, products or
applications, or the Company's business initiatives will take
longer, cost more or produce lower benefits than anticipated, (c)
the possibility that application of or compliance with laws, court
rulings, regulations, certifications or other requirements or
standards may delay or prevent new product introductions, affect
the production and marketing of existing products, or otherwise
affect Company performance, results, or value, (d) the potential of
international unrest or effects of fluctuations in currencies, tax
assessments or rates, raw material costs, benefit or retirement
plan costs, or other regulatory compliance costs, (e) the
possibility of reduced demand, or reductions in the rate of growth
in demand, for the Company's products and services, and (f) the
possibility that anticipated cost savings may not be achieved, or
that transition, labor, competition, timing, execution, regulatory,
governmental, or other issues or risks associated with the matters
described in the referenced conference call may adversely impact
Company performance, results, or value. DATASOURCE: STERIS
Corporation CONTACT: Julie Winter, Manager, Investor Relations of
STERIS Corporation, +1-440-392-7245 Web Site:
http://www.steris.com/
Copyright